St. Jude Medical Inc.'s /quotes/zigman/242119/quotes/nls/stj STJ -0.79% second-quarter earnings fell 5.2% on restructuring-related charges as the medical-device maker posted sales growth and benefitted from currency fluctuations. For the year, the company lowered its per-share earnings forecast by three cents to $3.25 to $3.30. For current quarter, the company projected per-share earnings of 74 cents to 76 cents, below views of analysts polled by Thomson Reuters for 80 cents. U.S. defibrillator sales have been under pressure recently from lower procedure volumes and a negative study earlier this year.
